Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Erasmus Medical Center | OTHER |
| Cantonal Hospital of Aarau, Switzerland | OTHER |
| Spital Solothurn, Switzerland | UNKNOWN |
| Cantonal Hospital of St. Gallen |
Not provided
Not provided
Not provided
Not provided
Hyponatremia is the most common electrolyte disorder with a prevalence of up to 30% in hospitalized patients. While treatment of acute hyponatremia with severe clinical symptoms due to cerebral edema is undisputed and straightforward, hyponatremia in general is usually considered asymptomatic or not clinically relevant. Accordingly, a recent observational study showed that appropriate laboratory tests to evaluate the etiology of hyponatremia were obtained in less than 50% of patients, leading to 75% of patients being still hyponatremic at discharge.
This is problematic in the context of increasing evidence, revealing an association of chronic hyponatremia with adverse effects such as gait alterations and falls, attention deficits, bone loss and fractures as well as disease-associated morbidity leading to increased rates of readmissions and mortality. Yet, there is a complete lack of randomized clinical trials with the primary aim to investigate whether correction of plasma sodium concentration counteracts the elevated risk of rehospitalization and mortality.
The aim of this trial is therefore to determine the effects on mortality and rehospitalization rate of a targeted correction of plasma sodium concentration in addition to current standard care in hospitalized hyponatremic patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Standard care plus targeted correction of hyponatremia | Experimental | Diagnosis and treatment of hyponatremia will be standardized according to the European Clinical Practice Guidelines (ECPG). Treatment response and adherence will be evaluated daily and treatment adapted if treatment goals are not reached.Targeted correction of plasma sodium Levels. |
|
| Standard care | Active Comparator | Diagnosis and treatment of hyponatremia will be solely at the discretion of the attending physicians who are in no way involved in the trial. The study team will not intervene with the treatment in any way. Diagnostic and treatment decisions as well as course of the plasma sodium level will only be recorded after patient is discharged from hospital using the medical records and patient charts. It will be generally recommended to measure plasma sodium levels 3x weekly or more frequently if clinically indicated, at discharge and after 30 days. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Targeted correction of plasma sodium levels | Other | Targeted correction of hyponatremia |
|
| Measure | Description | Time Frame |
|---|---|---|
| The primary outcome is the combined risk of death or rehospitalization within 30 days | Rate of death or rehospitalization within 30 days | 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| 30 days mortality rate | Mortality rate | 30 days |
| 1 year mortality rate | Mortality rate | 1 year |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mirjam Christ-Crain, Prof. MD | University Hospital, Basel, Switzerland | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital Centre Zagreb | Zagreb | 10000 | Croatia | |||
| Uniklinik Köln |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41733398 | Derived | Refardt J, Potasso L, Pelouto A, Trappe M, Gregoriano C, Koster M, Vodanovic ID, Norello D, Ravioli S, Cukoski S, Boesing M, Ryser B, Sambula L, Rapsch N, Monnerat S, Beck J, Lustenberger S, Vogt DR, Werlen L, de Jesus JS, Bontognali M, Schuetz P, Zandbergen AAM, Peri A, Kastelan D, Lindner G, Leuppi J, Bilz S, Mueller B, Burst V, Hoorn EJ, Christ-Crain M. A Randomized Trial of Targeted Hyponatremia Correction in Hospitalized Patients. NEJM Evid. 2026 Mar;5(3):EVIDoa2500086. doi: 10.1056/EVIDoa2500086. Epub 2026 Feb 24. | |
| 34552947 |
Not provided
Not provided
Metadata describing the type, size and content of the datasets will be shared along with the study protocol and case report forms on the public repository dataverse.harvard.edu.
Not provided
Not provided
Not provided
| OTHER |
| Kantonsspital Liestal, Switzerland | UNKNOWN |
| Universitätsklinikum Köln | OTHER |
| KBC Zagreb, Croatia | UNKNOWN |
| Azienda Ospedaliero-Universitaria Careggi | OTHER |
Randomized, controlled, parallel-group trial
Not provided
Not provided
Outcome assessors will be blinded to allocated treatment group
| Standard care | Other | Standard care of hyponatremia |
|
| 30 days rehospitalization rate | Rehospitalization rate | 30 days |
| 1 year rehospitalization rate | Rehospitalization rate | 1 year |
| Time to rehospitalization | Days until first rehospitalization | up to 1 year |
| Time to death | Days until death | up to 1 year |
| length of hospital stay | length of index hospital stay in days | up to 1 year |
| Rate of falls | Number of falls | 30 days |
| Rate of fractures | Number of bone fractures | 30 days |
| Rate of fractures | Number of bone fractures | 1 year |
| Rate of Plasma sodium normalization at discharge | Rate of Plasma sodium Levels >=135mmol/L at discharge | up to 1 year |
| Change in Plasma sodium Levels | Change in mmol/L in Plasma sodium Levels from inclusion to discharge | up to 1 year |
| Recurrence of hyponatremia | Rate of recurrence of hyponatremia | 30 days |
| Recurrence of hyponatremia | Rate of recurrence of hyponatremia | 1 year |
| Severely symptomatic hyponatremia | Rate of severely symptomatic hyponatremia requiring intensive care Treatment during index hospitalization | up to 1 year |
| Sodium-overcorrection | Rate of plasma sodium overcorrection during index hospitalization | up to 1 year |
| number of adverse events | Rate of adverse events | 30 days |
| number of adverse events | Rate of adverse events | 1 year |
| Severe adverse events | Rate of severe adverse events | 30 days |
| Severe adverse events | Rate of severe adverse events | 1 year |
| Diagnostic accuracy of copeptin in the diagnosis of hyponatremia | Copeptin Level will be correlated with final hyponatremia diagnosis | 1 day |
| Diagnostic accuracy of mid-regional mid-regional (MR)-proANP in the diagnosis of hyponatremia | MR-proANP Level will be correlated with final hyponatremia diagnosis N-terminal (NT)-proBNP, aldosterone, renin) | 1 day |
| Diagnostic accuracy of NT-proBNP in the diagnosis of hyponatremia | NT-proBNP Level will be correlated with final hyponatremia diagnosis | 1 day |
| Diagnostic accuracy of aldosterone in the diagnosis of hyponatremia | Aldosterone Level will be correlated with final hyponatremia diagnosis | 1 day |
| Diagnostic accuracy of renin in the diagnosis of hyponatremia | Renin Level will be correlated with final hyponatremia diagnosis | 1 day |
| Cologne |
| 50937 |
| Germany |
| Careggi University Hospital Florence | Florence | 50134 | Italy |
| Erasmus Medical Center Rotterdam | Rotterdam | 3015 GD | Netherlands |
| University Hospital Basel, Department of Endocrinology | Basel | Canton of Basel-City | 4031 | Switzerland |
| Kantonsspital Aarau | Aarau | 5001 | Switzerland |
| Kantonsspital Baselland | Liestal | 4410 | Switzerland |
| Kantosspital St. Gallen | Sankt Gallen | 9000 | Switzerland |
| Solothurner Spitäler AG | Solothurn | 4500 | Switzerland |
| Derived |
| Refardt J, Pelouto A, Potasso L, Hoorn EJ, Christ-Crain M. Hyponatremia Intervention Trial (HIT): Study Protocol of a Randomized, Controlled, Parallel-Group Trial With Blinded Outcome Assessment. Front Med (Lausanne). 2021 Sep 6;8:729545. doi: 10.3389/fmed.2021.729545. eCollection 2021. |
| ID | Term |
|---|---|
| D007010 | Hyponatremia |
| ID | Term |
|---|---|
| D014883 | Water-Electrolyte Imbalance |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D059039 | Standard of Care |
| ID | Term |
|---|---|
| D019984 | Quality Indicators, Health Care |
| D011787 | Quality of Health Care |
| D006298 | Health Services Administration |
| D017530 | Health Care Quality, Access, and Evaluation |
Not provided
Not provided